000			01590nam a2200325Ia 4500
001			0000073717
005			20171002053656.0
006			m u
007			cr cn|||||||||
008			040925s2004 dcu gsb 000 0 eng d
020			_z0309091721
035			_a(CaPaEBR)ebr10060421
035			_a(OCoLC)70772941
040			_aCaPaEBR _cCaPaEBR
050	1	4	_aR853.H8 _bI584 2004eb
245	0	0	_aIntentional human dosing studies for EPA regulatory purposes _h[electronic resource] : _bscientific and ethical issues / _cCommittee on the Use of Third Party Toxicity Research with Human Research Participants, Science, Technology, and Law Program, Policy and Global Affairs Division, National Research Council of the National Academies.
260			_aWashington, D.C. : _bNational Academies Press, _cc2004.
300			_axviii, 208 p.
504			_aIncludes bibliographical references.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2009. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
610	1	0	_aUnited States. _bEnvironmental Protection Agency.
650		0	_aHuman experimentation in medicine _xMoral and ethical aspects.
650		0	_aHuman experimentation in medicine _xGovernment policy _zUnited States.
650		0	_aMedical ethics.
650		0	_aMedicine _xResearch _xMoral and ethical aspects.
655		7	_aElectronic books. _2local
710	2		_aebrary, Inc.
856	4	0	_uhttp://site.ebrary.com/lib/daystar/Doc?id=10060421 _zAn electronic book accessible through the World Wide Web; click to view
908			_a170314
942	0	0	_cEB
999			_c62875 _d62875